Guggenheim Capital’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-530,246
| Closed | -$1.17M | – | 2689 |
|
|
2018
Q1 | $1.17M | Sell |
530,246
-100,803
| -16% | -$222K | ﹤0.01% | 1996 |
|
|
2017
Q4 | $1.26M | Buy |
631,049
+222,105
| +54% | +$442K | ﹤0.01% | 1961 |
|
|
2017
Q3 | $1.33M | Buy |
408,944
+4,969
| +1% | +$16.1K | ﹤0.01% | 1922 |
|
|
2017
Q2 | $1.3M | Buy |
+403,975
| New | +$1.3M | ﹤0.01% | 1915 |
|
|
2016
Q1 | – | Sell |
-15,635
| Closed | -$19K | – | 3016 |
|
|
2015
Q4 | $19K | Buy |
15,635
+4,931
| +46% | +$5.99K | ﹤0.01% | 2922 |
|
|
2015
Q3 | $18K | Sell |
10,704
-5,247
| -33% | -$8.82K | ﹤0.01% | 2899 |
|
|
2015
Q2 | $33K | Buy |
15,951
+3,266
| +26% | +$6.76K | ﹤0.01% | 2974 |
|
|
2015
Q1 | $34K | Buy |
12,685
+783
| +7% | +$2.1K | ﹤0.01% | 2959 |
|
|
2014
Q4 | $31K | Buy |
+11,902
| New | +$31K | ﹤0.01% | 2941 |
|
|
2014
Q3 | – | Sell |
-10,492
| Closed | -$28K | – | 3096 |
|
|
2014
Q2 | $28K | Buy |
+10,492
| New | +$28K | ﹤0.01% | 3097 |
|
|
2014
Q1 | – | Sell |
-11,481
| Closed | -$51K | – | 3291 |
|
|
2013
Q4 | $51K | Buy |
11,481
+688
| +6% | +$3.06K | ﹤0.01% | 2990 |
|
|
2013
Q3 | $44K | Buy |
10,793
+716
| +7% | +$2.92K | ﹤0.01% | 2886 |
|
|
2013
Q2 | $42K | Buy |
+10,077
| New | +$42K | ﹤0.01% | 2843 |
|